Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
20 Juni 2023 - 10:46PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER
PURSUANT TO RULE 13a-16
OR 15d-16 OF THE
SECURITIES EXCHANGE ACT
OF 1934
For the month of June 2023
Commission File Number: 001-39446
CureVac N.V.
(Exact Name of Registrant as Specified in Its
Charter)
Friedrich-Miescher-Strasse 15, 72076
Tübingen, Germany
+49 7071 9883 0
(Address of principal executive office)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F:
On June 20, 2023, CureVac N.V. (the “Company”) issued a
press release announcing the appointment of Mr. Michael Brosnan as a member of the Company’s Supervisory Board.
The information included in this Form 6-K (including Exhibit 99.1,
but excluding the statements of the Company’s Chairman of the Supervisory Board and of Mr. Michael Brosnan, contained in Exhibit 99.1
hereto) is hereby incorporated by reference into the Company’s Registration Statement on Form F-3 (File No. 333-259613).
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
CUREVAC N.V. |
|
|
|
|
By: |
/s/ Alexander Zehnder |
|
|
Chief Executive Officer |
Date: June 20, 2023
EXHIBIT INDEX
CureVac NV (NASDAQ:CVAC)
Historical Stock Chart
Von Mai 2024 bis Jun 2024
CureVac NV (NASDAQ:CVAC)
Historical Stock Chart
Von Jun 2023 bis Jun 2024